产品详情
  • 产品名称: CRL-1646 FO 小鼠骨髓瘤细胞

  • 产品型号: CRL-1646
  • 产品厂商:其它品牌
  • 产品文档:
你添加了1件商品 查看购物车
简单介绍:
简单介绍 CRL-1646 FO 小鼠骨髓瘤细胞, ATCC 细胞|细胞系|细胞株|肿瘤细胞|细胞,细胞库管理规范,提供的细胞株背景清楚,提供参考文献和**培养条件
详情介绍:

 

CRL-1646 FO 小鼠骨髓瘤细胞

ATCC® Number:  CRL-1646™      Price:  $355.00 
Designations:  FO 
Depositors:   SF de St. Groth 
Biosafety Level: 1 
Shipped:  frozen 
Medium & Serum:  See Propagation 
Growth Properties: suspension
Organism: Mus musculus (mouse) 
Morphology: lymphoblast

 
Source: Disease: plasmacytoma; myeloma
Strain: BALB/c
Cell Type: B lymphoblast;
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. 
 
Antigen Expression: H-2d
Comments: The line was line created by self fusing Sp2/0 myeloma cells using Sendai virus.
The cells are resistant to 8-azaguanine and do not produce immunoglobulin.
The line can be used a fusion partner for making B cell hybridomas.
Tested and found negative for ectromelia virus (mousepox).
Propagation:  ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Temperature: 37.0°C
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Subculturing:  Medium Renewal: Every 2 to 3 days
Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 0.5 to 1 X 10 exp5 viable cells/ml.
Maintain cell density between 1 X 10 exp5 and 1 X 10 exp6 viable cells/ml.
Preservation:  culture medium 95%; DMSO, 5%
Doubling Time:  8 to 10 hrs 
Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002
recommended serum:ATCC 30-2020
References: 1092: de St.Groth SF, Scheidegger D. Production of monoclonal antibodies: strategy and tactics. J. Immunol. Methods 35: 1-21, 1980. PubMed: 7009747
 Related Links  
NCBI Entrez Search 
Make a Deposit 
Frequently Asked Questions 
Material Transfer Agreement 
Technical Support 
Related Cell Culture Products  
 
 

沪公网安备 31010902002433号